NL-OMON30577尚未招募3 期
A prospective, randomized, open, multicenter study to evaluate the efficacy and tolerability of induction therapy with a single high-dose anti-T-lymphocyte globulin (ATG-Fresenius) in renal transplant patients with a kidney from a non-heart-beating donor and tacrolimus, mycophenolate mofetil, and steroids as basic immunosuppression. - ATG induction in renal transplant patients with a NHBD kidney/NHBD-ATG
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients will receive information related to the clinical trial and have to give written informed consent.;1. Non-heart-beating-donors (Maastricht III/IV)
- •2. Female patients of childbearing age agree to maintain effective birth control practice during the study.
排除标准
- •1. Pregnant or lactating women at the time of randomization.
- •2. Patients and donors are ABO incompatible.
- •3. Women having had >3 pregnancies (including abortions if no consistent data on PRA or anti-donor antibodies are available).
- •4. Patients with hypersensibility to rabbit proteins, previous treatment with rabbit IgG, or known intolerance to any component of basal immunosuppression.
- •5. Patients with leukocytes <3,000/mm3 and/or platelets <50,000/mm3 before initiation of transplant.
- •6. Patients, who are HIV positive.
- •7. Patients, who are candidates for multiple transplants (e.g. SKP).
- •8. Patients, who are unlikely to comply with the visit schedule in the protocol and patients who cannot communicate reliably with the investigator.
- •9. Patients with pulmonary oedema or with other signs of overhydration.
研究者
相似试验
进行中（未招募）
不适用
A prospective, randomized, open, multicenter study to evaluate the efficacy and tolerability of induction therapy with a single high-dose anti-T-lymphocyte globulin (ATG-Fresenius) in renal transplant patients with a kidney from a non-heart-beating donor and tacrolimus, mycophenolate mofetil, and steroids as basic immunosuppression. - NHB-ATGTransplantation of a renal graft from a non-heart-beating donorEUCTR2007-000210-36-NLMC St Radboud University Hospital Center
已完成
不适用
Mycophenolate sodium versus Everolimus or Cyclosporine with Allograft Nephropathy as OutcomeRenal transplantSurgeryTransplanted organs and tissue statusISRCTN69188731Academic Medical Center (AMC), Renal Transplant Unit (The Netherlands)255
尚未招募
4 期
A prospective, multicenter, randomized, open study on the efficacy and safety of Yisaipu combined with traditional Chinese medicine for standard treatment and maintenance therapy in RA patients who failed traditional DMARDs treatmentRheumatoid arthritisITMCTR1900002628Guang'anmen Hospital, China Academy of Chinese Medical Sciences
已完成
不适用
CAlciNeurin-inhibitor Nephrotoxicity and Efficacy StudyRenal transplantInjury, Occupational Diseases, PoisoningFailure and rejection of transplanted organs and tissuesISRCTN55817881eiden University Medical Centre (LUMC) (The Netherlands)126
进行中（未招募）
不适用
A prospective, randomized, open, multi-centre study to assess safety of PURETHAL Grasses given with a rush induction schedule to patients with allergic rhinoconjunctivitis. - PURETHAL Grasses Rush studyAllergic (IgE-mediated) rhinitis/rhinoconjunctivitis due to sensitization to grass pollenMedDRA version: 12.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisMedDRA version: 12.0Level: LLTClassification code 10001726Term: Allergic rhinitis due to pollenMedDRA version: 12.0Level: LLTClassification code 10053741Term: Allergenic desensitization procedureEUCTR2009-015012-18-DEHAL Allergy BV